covid image - sci

MVLS Research Outputs

Discover and explore the research currently being undertaken across our seven research institutes in response to the Covid19 pandemic.

Institute of Biodiversity, Animal Health & Comparative Medicine

Covid19 Publications

Collier, D. A. et al. (2021) Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature, (doi: 10.1038/s41586-021-03412-7) (PMID:33706364) (Early Online Publication)

Hanlon, P. et al. (2020) COVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study. Wellcome Open Research, 5, 75. (doi: 10.12688/wellcomeopenres.15849.1) (PMID:PPR153916)

Olival, K. J. et al. (2020) Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: a case study of bats. PLoS Pathogens, 16(9), e1008758. (doi: 10.1371/journal.ppat.1008758) (PMID:32881980) (PMCID:PMC7470399)

Da Silva Filipe, A. et al. (2021) Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland. Nature Microbiology, 6(1), pp. 112-122. (doi: 10.1038/s41564-020-00838-z) (PMID:33349681)

McDougall, C. W., Brown, C., Thomson, C., Hanley, N. , Tully, M. A., Quilliam, R. S., Bartie, P. J., Gibson, L. and Oliver, D. M. (2020) From one pandemic to another: emerging lessons from COVID-19 for tackling physical inactivity in cities. Cities and Health, (doi: 10.1080/23748834.2020.1785165) (Early Online Publication)

Rihn, S. J. et al. (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biology, 19(2), e3001091. (doi: 10.1371/journal.pbio.3001091) (PMID:33630831)

Hosie, M. J. et al. (2021) Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission. Veterinary Record, (Accepted for Publication)

Murcia, P. , Streiker, D. , Da Silva Filipe, A. , Robertson, D. , Jarrett, R. , Willett, B. , Hosie, M. , Biek, R. , Allan, K. and Weir, W. (2020) Send cat and dog samples to test for SARS-CoV-2. Veterinary Record, 186(17), p. 571. (doi: 10.1136/vr.m2019) (PMID:32451348)

Kronfeld-Schor, N., Stevenson, T., Nickbakhsh, S. , Schernhammer, E., Dopico, X., Dayan, T., Martinez, M. and Helm, B. (2021) Drivers of infectious disease seasonality: potential implications for COVID-19. Journal of Biological Rhythms, 36(1), pp. 35-54. (doi: 10.1177/0748730420987322) (PMID:33491541) (PMCID:PMC7924107)

Addie, D., Houe, L., Maitland, K. , Passantino, G. and Decaro, N. (2020) Effect of cat litters on feline coronavirus infection of cell culture and cats. Journal of Feline Medicine and Surgery, 22(4), pp. 350-357. (doi: 10.1177/1098612x19848167) (PMID:31094626)

Ceron, J. J., Lamy, E., Martinez-Subiela, S., Lopez-Jornet, P., Capela e Silva, F., Eckersall, P. D. and Tvarijonaviciute, A. (2020) Use of saliva for diagnosis and monitoring the SARS-CoV-2: a general perspective. Journal of Clinical Medicine, 9(5), e1491. (doi: 10.3390/jcm9051491) (PMID:32429101) (PMCID:PMC7290439)

Institute of Cancer Sciences

Covid19 Publications

Keith, N. , Plummer, R., Coyle, V., Cameron, D., Evans, J. , Twelves, C., Palmer, D., Danson, S., Graham, D. and Welisch, G. (2021) Early Phase Cancer Research in the COVID-19 Pandemic: an ECMC North Initiative. Project Report. OSF. (doi:10.17605/OSF.IO/6WTN2).

Duffy, C. et al. (2020) Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter. BMJ Open, 7, e000710. (doi: 10.1136/bmjresp-2020-000710) (PMID:33148778) (PMCID:PMC7643431)

McKay, S. C. et al. (2021) Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. HPB, (doi: 10.1016/j.hpb.2021.03.003) (PMCID:PMC7973054) (In Press)

Hadjiyiannakis, D., Dimitroyannis, D., Eastlake, L., Peedell, C., Tripathi, L., Simcock, R., Vyas, A., Deutsch, E. and Chalmers, A.J. (2021) Personal view: low-dose lung radiotherapy should be evaluated as a treatment for severe COVID-19 lung disease. Clinical Oncology, 33(1), e64-e68. (doi: 10.1016/j.clon.2020.08.003) (PMID:32829986) (PMCID:PMC7427522)

Ferguson, K., Quail, N., Kewin, P. and Blyth, K. G. (2020) COVID-19 associated with extensive pulmonary arterial, intracardiac and peripheral arterial thrombosis. BMJ Case Reports, 13(8), e237460. (doi: 10.1136/bcr-2020-237460) (PMID:32747597) (PMCID:PMC7401579)

Faivre-Finn, C. et al. (2020) Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic. Clinical Oncology, 32(8), pp. 481-489. (doi: 10.1016/j.clon.2020.05.001) (PMID:32405158) (PMCID:PMC7218369)

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1) (PMID:33213530) (PMCID:PMC7675389)

O'Cathail, S.M. , Gilbert, D.C., Sebag-Montefiore, D. and Muirhead, R. (2020) Challenges and consequences of COVID-19 in the management of anorectal cancer: coming together through social distancing. Clinical Oncology, 32(7), pp. 413-416. (doi: 10.1016/j.clon.2020.04.009) (PMID:32359847) (PMCID:PMC7184022)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)

Conway, D.I. et al. (2021) SARS-CoV-2 positivity in asymptomatic-screened dental patients. Journal of Dental Research, (doi: 10.1177/00220345211004849) (PMID:33779355) (Early Online Publication)

Boyle, J. G., Walters, M. R. , Jamieson, S. and Durning, S. J. (2020) Clinical reasoning in the wild: premature closure during the COVID-19 pandemic. Diagnosis, 7(3), pp. 177-179. (doi: 10.1515/dx-2020-0061) (PMID:32710716)

Stenvinkel, P., Painer, J., Shiels, P.G. , Bansal, A., Fereidouni, S., Natterson-Horowitz, B., Johnson, R.J. and Miranda, J.J. (2021) SARS-COV-2 and biomimetics: what saves the planet will save our health. Journal of Internal Medicine, 289(2), pp. 244-246. (doi: 10.1111/joim.13128) (PMID:32583447) (PMCID:PMC7361468)

Emary, K. R. W. et al. (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet, (doi: 10.1016/S0140-6736(21)00628-0) (In Press)

Hanna, C. R. , Robb, K. A. , Blyth, K. G. , Jones, R. J. and Chalmers, A. J. (2021) Clinician attitudes to using low dose radiotherapy to treat COVID-19 lung disease. International Journal of Radiation Oncology, Biology, Physics, 109(4), pp. 886-890. (doi: 10.1016/j.ijrobp.2020.12.003) (PMID:33309910) (PMCID:PMC7726525)

Jones, C. M. et al. (2020) Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. British Journal of Cancer, 123(5), pp. 709-713. (doi: 10.1038/s41416-020-0980-x) (PMID:32641867) (PMCID:PMC7341025)

Institute of Cardiovascular & Medical Sciences 

Covid19 Cardiovascular Research

Please see our ICAMS Covid19 Cardiovascular Research pages for all current projects, publications and outputs. 


Institute of Health & Wellbeing

Covid19 Publications

There seems to be a problem with the publications at the moment. Please try again later.

Grants Awarded for Covid19 Research

  • Chief Scientist Office. Understanding longer-term health impacts of social distancing and
    behavioural interventions introduced to prevent the spread of infection in the populationDr Katie Robb (PI) & Professor Rory O’Connor. £37,000.
  • Hunt K, Stead M, Purves R, Bunn C, Gray C, Reith G, Wardle H, Dobbie F, Critchlow N, Donnachie A. Transitions to more harmful forms of gambling during Covid-19 pandemic: behaviours and targeted marketing in young people and bettors on sport. ESRC £464,387. Jun 2020-Dec 2021.
  • Gray CM, O’Donnell K, Wyke S part of a Scotland-wide consortium of 33 behavioural scientists Protecting population physical & mental health during the coronavirus pandemic: A representative national weekly survey to understand changes. CSO £324,472. May 2020-Nov 2020.
  • Shakespeare T, Watson N, Burns N, Pearson C, Wiseman P, Banks M and Kupar H. Disability and Covid 19. The aim of this study is to understand disabled people's experiences during the COVID-19 epidemic, barriers experienced and lessons learned for policy and  practice. £390,000 ESRC COVID-19 Rapid Response research call
  • Crampin A, Mwansambo C, Chauma Mwale A, Madise N, Ho A, Mwapasa V, Nyirenda T, Read J, Jewell C, MacPherson P, Price A, Amoah ASARS-CoV-2 immunoepidemiology in Wellcome-funded urban andrural cohorts in Malawi : generating evidence to inform regional medium and long term decision making. Wellcome £249,544.00
  • Hatton, C., Hastings, R, Abbott, D., Beyer, S., Bradshaw, J., Gore, N., Heslop, P., Jahoda, A., Marriot, A., Scior, K., Taggart, L., and Todd, S. Title: The impact of the COVID-19 pandemic on people with learning disabilities and factors associated with better outcomes. MRC award, £763,431 (September 2020- 2021)
  • Prof Kate O’Donnell as PI; Dr Sara Macdonald and Dr David Blane as Co-Is. Title: Patient and public understanding of, and preferences for, digital tools to support the Scottish Test, Trace, Isolate, Support programme for COVID-19 infection. DHI/PHS; £30,000. (June – August 2020).
  • How has Covid-19 social distancing amplified the mental health vulnerabilities of gay, bisexual and other men who have sex with men (GBM)?  Dr Jamie Frankis, Reader in Health Psychology, GCU, Prof P Flowers, U. Strathclyde; Prof L McDaid, U. Glasgow; Dr D Strongylou, R Kincaid, GCU, J Heng, NHS Glasgow; T Tougher, NHS Lanarkshire; Y Kerr & Dr D Clutterbuck, NHS Lothian; Dr L Wallace, HPS; N Sparling, HIV Scotland.  CSO £49,728 
  • Social and health impacts of COVID-19 suppression in vulnerable groupsProf Sarah ArmstrongDr Lucy Pickering - CSO £186,869

 


MRC/CSO Social and Public Health Sciences Unit

Robertson Centre for Biostatistics

The Roberson Centre for Biostatistics are involved as co-applicants/partners in the undernoted Covid19-related grants:

  • UKRI NIHR - Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: the COVID-HEART study - Prof Colin J Berry, Robertson Centre (Data Management, Statistics, Project Management, ECGs] – Total Grant award £620,076
  • Medical Research Scotland – The influence of COVID-19 pandemic on the Scottish congenital heart disease populationDr Mark Danton, Professor J G Cleland, Professor Alex McConnachieMs Sharon Kean – Total Grant Award £20,000
  • Medical Research Scotland - Right Ventricular Dysfunction in Ventilated Patients with COVID-19 (COVID-RV)Dr Ben Shelley, Professor Colin J Berry, Dr Claudia-Martina Messow – Total Grant Award £18,280
  • Chief Scientists Office – Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19)Professor Colin J Berry, Professor Alex McConnachieMs Sharon Kean – Total Grant Award £47,940
  • Medical Research Scotland - 3D Telemedicine: Transforming Patient Communication during Covid-19Dr Steven Lo, Robertson Centre [Statistics] - Total Grant Award £19,829

Additional advisory roles and outputs:

  • RCB provides technical support for Professor Pell to analyse data in the Glasgow SafeHaven to inform the Health Board’s strategy on COVID-19 ‘shielding’.
  • The RCB team has also created several UK national registries (supported by the British Cardiovascular Society) to capture cardiovascular complications and interventions associated with COVID-19,
  • Dr Pierpaolo Pellicori (Clinical Senior Lecturer) is leading a Cochrane Rapid Review on cardiovascular complications of COVID-19.

Covid19 Advisory Roles

SPHSU

  • Dr Elise Whitley is a member of Public Health Scotland’s Mental Health Cell and currently contributing to priority setting for future work and advising on likely data sources for monitoring.
  • Dr Eric Silverman is a member of Covid-19 Healthcare Coalition which is developing a decision-support dashboard intended to help policy-makers in the US to monitor the progress of the pandemic at the state and county level throughout the country.
  • Professor Rich Mitchell and Dr Jonathan Olsen are on Public Health Scotland's Social and System Recovery: Environments and Spaces Group. Rich is leading their Evidence and Data subgroup.
    The group is currently exploring the implications of the COVID-19 pandemic for open spaces, parks, streets, public spaces.
  • Ms Ruth Dundas is part of The Scottish COVID-19 Response Consortium (SCRC) - a group of epidemiologists, mathematical modellers, data scientists, software developers and other scientists that have come together to develop new models to help inform the control of COVID-19.
  • One of the key groups identified by RAMP to develop a wider range of pandemic models is the University of Glasgow led Scottish COVID-19 Response Consortium. SPHSU is involved in curating data to support model specification and calibration, and we will be increasingly involved in model design and programming.
  • Dr Vittal Katikireddi is co-chair and Dr Rachel ThomsonDr Theocharis Kromydas and Dr Peter Craig are members of a group convened by Public Health Scotland to advise the Scottish Government and other stakeholders (e.g. CoSLA, Social Security Scotland) on the impacts of the COVID-19 response on health and health inequalities that arise through economic and related pathways, and on actions that may mitigate negative impacts and enhance positive impacts. The group has published a briefing looking at protecting the health of the working-age population as lockdown reduces. 

Other Covid19 Outputs

INS (International Neuropsychological Society) Newsletter

  • Narayanan, J., Evans, J.J., & Wilson, B.A., (2020) Balint’s syndrome as a consequence of COVID-19: A case from Southern India. INS News: International Neuropsychological Society Member Newsletter, Issue 3, p27-31

BMJ Editorial

Public Health Scotland Report


Institute of Infection, Immunity & Inflammation

Covid19 Publications

Zumla, A., Alagaili, A. N., Cotten, M. and Azhar, E. I. (2016) Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV). BMC Medicine, 14, 132. (doi: 10.1186/s12916-016-0686-3) (PMID:27604081) (PMCID:PMC5015245)

McInnes, I. B. (2020) COVID-19 and rheumatology: first steps towards a different future? Annals of the Rheumatic Diseases, 79(5), pp. 551-552. (doi: 10.1136/annrheumdis-2020-217494) (PMID:32299844)

Chaziya, J. et al. (2021) COVID-19 in Malawi: lessons in pandemic preparedness from a tertiary children’s hospital. Archives of Disease in Childhood, 106, pp. 238-240. (doi: 10.1136/archdischild-2020-319980) (PMID:33361067) (PMCID:PMC7768613)

Memish, Z. A. et al. (2014) Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerging Infectious Diseases, 20(6), pp. 1012-1015. (doi: 10.3201/eid2006.140402) (PMID:24857749) (PMCID:PMC4036761)

Morgan, D. C. et al. (2021) Stapled ACE2 peptidomimetics designed to target the SARS-CoV-2 spike protein do not prevent virus internalisation. Peptide Science, (doi: 10.1002/pep2.24217) (Early Online Publication)

Wood, R. et al. (2021) Sharing a household with children and risk of COVID-19: a study of over 300 000 adults living in healthcare worker households in Scotland. Archives of Disease in Childhood, (doi: 10.1136/archdischild-2021-321604) (PMID:33737319) (PMCID:PMC7985971) (Early Online Publication)

MacLean, O. A. , Lytras, S., Weaver, S., Singer, J. B., Boni, M. F., Lemey, P., Kosakovsky Pond, S. L. and Robertson, D. L. (2021) Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen. PLoS Biology, 19(3), e3001115. (doi: 10.1371/journal.pbio.3001115) (PMID:33711012)

Mehta, P., Porter, J. C., Manson, J. J., Isaacs, J. D., Openshaw, P. J.M., McInnes, I. B. , Summers, C. and Chambers, R. C. (2020) Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities. Lancet Respiratory Medicine, 8(8), pp. 822-830. (doi: 10.1016/S2213-2600(20)30267-8) (PMID:32559419)

Pollock, D. D. et al. (2020) Viral CpG deficiency provides no evidence that dogs were intermediate hosts for SARS-CoV-2. Molecular Biology and Evolution, 37(9), pp. 2706-2710. (doi: 10.1093/molbev/msaa178) (PMID:32658964) (PMCID:PMC7454803)

Sigfrid, L. et al. (2021) What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open, 11(3), e043887. (doi: 10.1136/bmjopen-2020-043887) (PMID:33692181) (PMCID:PMC7948153)

Carson, G. and Long Covid Forum Group, (2021) Research priorities for Long Covid: refined through an international multi-stakeholder forum. BMC Medicine, 19(1), 84. (doi: 10.1186/s12916-021-01947-0) (PMID:33785027) (PMCID:PMC8009733)

Hughes, E. C. et al. (2021) Severe Acute Respiratory Syndrome Coronavirus 2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity according to host demography and healthcare setting. Journal of Infectious Diseases, 223(6), pp. 971-980. (doi: 10.1093/infdis/jiaa788) (PMID:33367847) (PMCID:PMC7798933)

Cotten, M. et al. (2013) Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet, 382(9909), pp. 1993-2002. (doi: 10.1016/S0140-6736(13)61887-5) (PMID:24055451) (PMCID:PMC3898949)

Nickbakhsh, S. , Ho, A. , Marques, D. F.P., McMenamin, J., Gunson, R. N. and Murcia, P. R. (2020) Epidemiology of seasonal coronaviruses: establishing the context for the emergence of coronavirus disease 2019. Journal of Infectious Diseases, 222(1), pp. 17-25. (doi: 10.1093/infdis/jiaa185) (PMID:32296837) (PMCID:PMC7184404)

Thomson, E. C. et al. (2021) Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell, 184(5), 1171-1187.e20. (doi: 10.1016/j.cell.2021.01.037) (PMID:33621484) (PMCID:PMC7843029)

Gupta, R. K. et al. (2021) Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respiratory Medicine, 9(4), pp. 349-359. (doi: 10.1016/S2213-2600(20)30559-2) (PMID:33444539) (PMCID:PMC7832571)

Cevik, M., Bamford, C. and Ho, A. (2020) COVID-19 Pandemic – a focused review for clinicians. Clinical Microbiology and Infection, 26(7), pp. 842-847. (doi: 10.1016/j.cmi.2020.04.023) (PMID:32344166) (PMCID:PMC7182753)

Da Silva Filipe, A. et al. (2021) Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland. Nature Microbiology, 6(1), pp. 112-122. (doi: 10.1038/s41564-020-00838-z) (PMID:33349681)

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1) (PMID:33213530) (PMCID:PMC7675389)

Rihn, S. J. et al. (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biology, 19(2), e3001091. (doi: 10.1371/journal.pbio.3001091) (PMID:33630831)

Hosie, M. J. et al. (2021) Detection of SARS-CoV-2 in respiratory samples from cats in the UK associated with human-to-cat transmission. Veterinary Record, (Accepted for Publication)

Voysey, M. et al. (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet, 397(10269), pp. 99-111. (doi: 10.1016/S0140-6736(20)32661-1) (PMID:33306989) (PMCID:PMC7723445)

Dee, K., Goldfarb, D. M., Haney, J., Amat, J. A.R., Herder, V., Stewart, M., Szemiel, A. M., Baguelin, M. and Murcia, P. R. (2021) Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology. Journal of Infectious Diseases, (doi: 10.1093/infdis/jiab147) (Early Online Publication)

Mangion, K. et al. (2020) The Chief Scientist Office cardiovascular and pulmonary imaging in SARS Coronavirus disease-19 (CISCO-19) study. Cardiovascular Research, 116(14), pp. 2185-2196. (doi: 10.1093/cvr/cvaa209) (PMID:32702087) (PMCID:PMC7454350)

Kronfeld-Schor, N., Stevenson, T., Nickbakhsh, S. , Schernhammer, E., Dopico, X., Dayan, T., Martinez, M. and Helm, B. (2021) Drivers of infectious disease seasonality: potential implications for COVID-19. Journal of Biological Rhythms, 36(1), pp. 35-54. (doi: 10.1177/0748730420987322) (PMID:33491541) (PMCID:PMC7924107)

Murcia, P. , Streiker, D. , Da Silva Filipe, A. , Robertson, D. , Jarrett, R. , Willett, B. , Hosie, M. , Biek, R. , Allan, K. and Weir, W. (2020) Send cat and dog samples to test for SARS-CoV-2. Veterinary Record, 186(17), p. 571. (doi: 10.1136/vr.m2019) (PMID:32451348)

Conway, D.I. et al. (2021) SARS-CoV-2 positivity in asymptomatic-screened dental patients. Journal of Dental Research, (doi: 10.1177/00220345211004849) (PMID:33779355) (Early Online Publication)

McInnes, I. (2021) Response to: 'Hydroxychloroquine shortages during the COVID-19 pandemic' by Mendel et al. Annals of the Rheumatic Diseases, 80, e32. (doi: 10.1136/annrheumdis-2020-217954) (PMID:32434826)

Kiyuka, P. K. et al. (2018) Human coronavirus NL63 molecular epidemiology and evolutionary patterns in rural coastal Kenya. Journal of Infectious Diseases, 217(11), pp. 1728-1739. (doi: 10.1093/infdis/jiy098) (PMID:29741740) (PMCID:PMC6037089)

Maguire, D. et al. (2020) Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection. Journal of Translational Medicine, 18, 354. (doi: 10.1186/s12967-020-02524-4) (PMID:32933530) (PMCID:PMC7491021)

Guzik, T. J. et al. (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research, 116(10), pp. 1666-1687. (doi: 10.1093/cvr/cvaa106) (PMID:32352535) (PMCID:PMC7197627)

da Silva, S. J. R., da Silva, C. T. A., Guarines, K. M., Mendes, R. P. G., Pardee, K., Kohl, A. and Pena, L. (2020) Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infectious Diseases, 6(9), pp. 2319-2336. (doi: 10.1021/acsinfecdis.0c00274) (PMID:32786280) (PMCID:PMC7441751)

Harrison, E. M. et al. (2020) Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients. SSRN Electronic Journal, (doi: 10.2139/ssrn.3618215) (Submitted)

Pairo-Castineira, E. et al. (2021) Genetic mechanisms of critical illness in Covid-19. Nature, 591, pp. 92-98. (doi: 10.1038/s41586-020-03065-y) (PMID:33307546)

Knight, S. R. et al. (2020) Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. British Medical Journal, 2020, 370. (doi: 10.1136/bmj.m3339) (PMID:32907855)

Memish, Z. A., Cotten, M. , Watson, S. J., Kellam, P., Zumla, A., Alhakeem, R. F., Assiri, A., Al Rabeeah, A. A. and Al-Tawfiq, J. A. (2014) Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. International Journal of Infectious Diseases, 23, pp. 63-68. (doi: 10.1016/j.ijid.2014.03.1372) (PMID:24699184) (PMCID:PMC4441753)

Hosie, M. J. et al. (2021) Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic. Viruses, 13(2), 185. (doi: 10.3390/v13020185)

Berto, A. et al. (2018) Detection of potentially novel paramyxovirus and coronavirus viral RNA in bats and rats in the Mekong Delta region of southern Viet Nam. Zoonoses and Public Health, 65(1), pp. 30-42. (doi: 10.1111/zph.12362) (PMID:28418192) (PMCID:PMC5811810)

Boni, M. F., Lemey, P., Jiang, X., Lam, T. T.-Y., Perry, B. W., Castoe, T. A., Rambaut, A. and Robertson, D. L. (2020) Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nature Microbiology, 5(11), pp. 1408-1417. (doi: 10.1038/s41564-020-0771-4) (PMID:32724171)

Assiri, A. et al. (2013) Hospital outbreak of Middle East respiratory syndrome coronavirus. New England Journal of Medicine, 369(5), pp. 407-416. (doi: 10.1056/NEJMoa1306742) (PMID:23782161) (PMCID:PMC4029105)

Emary, K. R. W. et al. (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet, (doi: 10.1016/S0140-6736(21)00628-0) (In Press)

Barry, M. et al. (2020) Nosocomial outbreak of the Middle East Respiratory Syndrome coronavirus: a phylogenetic, epidemiological, clinical and infection control analysis. Travel Medicine and Infectious Disease, 37, 101807. (doi: 10.1016/j.tmaid.2020.101807) (PMID:32599173) (PMCID:PMC7319941)

Banerjee, A. K. et al. (2020) SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell, (doi: 10.1016/j.cell.2020.10.004) (PMID:33080218) (PMCID:PMC7543886)

Docherty, A. B. et al. (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. British Medical Journal, 369, m1985. (doi: 10.1136/bmj.m1985) (PMID:32444460)

Sabir, S. R., Thomson, E. C. , Guzik, T. J., D’Acquisto, F. and Maffia, P. (2020) COVID-19: the new immune challenge. Frontiers for Young Minds, 8, 582971. (doi: 10.3389/frym.2020.582971)

Parker, M. D. et al. (2021) Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data. Genome Research, 31, pp. 645-658. (doi: 10.1101/gr.268110.120) (PMID:33722935)

Cevik, M., Tate, M., Lloyd, O., Maraolo, A. E., Schafers, J. and Ho, A. (2021) SARS-CoV-2, SARS-CoV-1 and MERS-CoV viral load dynamics, duration of viral shedding and infectiousness: a systematic review and meta-analysis. Lancet Microbe, 2(1), e13-e22. (doi: 10.1016/S2666-5247(20)30172-5)

Munblit, D. et al. (2021) The risk of overlooking children during the COVID-19 pandemic: Paediatric Long-COVID may be a ticking time bomb. Lancet Child and Adolescent Health, (Accepted for Publication)

Rutherford, M. A. et al. (2021) Risk factors for severe outcomes in patients with systemic vasculitis & COVID-19: a bi-national registry-based cohort study. Arthritis and Rheumatology, (doi: 10.1002/art.41728) (PMID:33750043) (Early Online Publication)

MacLean, O. A. , Orton, R. J. , Singer, J. B. and Robertson, D. L. (2020) No evidence for distinct types in the evolution of SARS-CoV-2. Virus Evolution, 6(1), veaa034. (doi: 10.1093/ve/veaa034) (PMID:32817804) (PMCID:PMC7197565)

Swann, O. V. et al. (2020) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. British Medical Journal, 370, m3249. (doi: 10.1136/bmj.m3249) (PMID:32960186) (PMCID:PMC7488201)

Silva, S. J. R. d., Germano Mendes, R. P., Alves da Silva, C. T., Lorusso, A., Kohl, A. and Pena, L. (2020) Insights into SARS-CoV-2, the coronavirus underlying COVID-19: recent genomic data and the development of reverse genetics systems. Journal of General Virology, 101(10), pp. 1021-1024. (doi: 10.1099/jgv.0.001458) (PMID:32579100) (PMCID:PMC7660456)

Volz, E. et al. (2021) Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity. Cell, 184(1), 64-75.e11. (doi: 10.1016/j.cell.2020.11.020) (PMID:33275900) (PMCID:PMC7674007)

Cotten, M. et al. (2014) Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. mBio, 5(1), e01062-13. (doi: 10.1128/mBio.01062-13) (PMID:24549846) (PMCID:PMC3944817)

Sattar, N. , McInnes, I. B. and McMurray, J. J.V. (2020) Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation, 142(1), pp. 4-6. (doi: 10.1161/CIRCULATIONAHA.120.047659) (PMID:32320270)

Zumla, A. et al. (2016) Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential. International Journal of Infectious Diseases, 47, pp. 5-9. (doi: 10.1016/j.ijid.2016.06.012) (PMID:27321961)

Institute of Molecular, Cell & Systems Biology

Institute of Neuroscience & Psychology